Nebula Research & Development’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-17,684
Closed -$582K 1108
2024
Q3
$582K Buy
+17,684
New +$582K 0.07% 496